Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

twin cities pool supplies pty ltd - chlorine present as sodium hypochlorite - liquid - chlorine present as sodium hypochlorite mineral-chlorine active 100.0 g/l - pool chlorine - swimming pool - algae | bacteria

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

twin cities pool supplies pty ltd - chlorine present as calcium hypochlorite - granular formulation - chlorine present as calcium hypochlorite mineral-chlorine active 650.0 g/kg - pool chlorine - swimming pool - algae | bacteria

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

twin cities pool supplies pty ltd - chlorine present as sodium dichloroisocyanurate - soluble powder - chlorine present as sodium dichloroisocyanurate mineral-chlorine active 630.0 g/kg - algicide - swimming pool (see label) | non stabilised pools | stabilised pools - algae | bacteria | chlorine stabiliser | increase longevity of chlorine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

twin cities pool supplies pty ltd - chlorine present as trichloroisocyanuric acid - tablet (inc. pellet, bolus, suppository, capsule) - chlorine present as trichloroisocyanuric acid mineral-chlorine-acid active 850.0 g/kg - pool chlorine - swimming pool - algae | bacteria

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis b surface antigen recombinant, quantity: 20 microgram/ml; hepatitis a virus antigen, quantity: 720 elisa unit/ml - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; aluminium phosphate; polysorbate 20; water for injections; neomycin sulfate; monobasic sodium phosphate; trometamol; sodium chloride; dibasic sodium phosphate heptahydrate; formaldehyde solution; acetic acid; glycine; leucine; phenylalanine; methionine; lysine hydrochloride; isoleucine; valine; histidine; threonine; tryptophan; alanine; arginine; proline; tyrosine; serine; sodium acetate; dibasic potassium phosphate; magnesium chloride hexahydrate - twinrix (720/20) is indicated for active immunisation against hepatitis a and hepatitis b virus infection in adults and children from 1 year of age. twinrix junior (360/10) is indicated for use in children aged 1 to 15 years. twinrix (720/20) is indicated for active immunisation against hepatitis a and hepatitis b virus infection in adults and children from 1 year of age. twinrix junior (360/10) is indicated for use in children aged 1 to 15 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis b surface antigen recombinant, quantity: 20 microgram/ml; hepatitis a virus antigen, quantity: 720 elisa unit/ml - injection, suspension - excipient ingredients: trometamol; aluminium hydroxide hydrate; sodium chloride; polysorbate 20; neomycin sulfate; water for injections; formaldehyde solution; aluminium phosphate; dibasic sodium phosphate heptahydrate; monobasic sodium phosphate; acetic acid; glycine; leucine; phenylalanine; methionine; lysine hydrochloride; isoleucine; valine; histidine; threonine; tryptophan; alanine; arginine; proline; tyrosine; serine; sodium acetate; dibasic potassium phosphate; magnesium chloride hexahydrate - twinrix (720/20) is indicated for active immunisation against hepatitis a and hepatitis b virus infection in adults and children from 1 year of age. twinrix junior (360/10) is indicated for use in children aged 1 to 15 years. twinrix (720/20) is indicated for active immunisation against hepatitis a and hepatitis b virus infection in adults and children from 1 year of age. twinrix junior (360/10) is indicated for use in children aged 1 to 15 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis b surface antigen recombinant, quantity: 20 microgram/ml; hepatitis a virus antigen, quantity: 720 elisa unit/ml - injection, suspension - excipient ingredients: dibasic sodium phosphate heptahydrate; neomycin sulfate; aluminium hydroxide hydrate; formaldehyde solution; trometamol; aluminium phosphate; water for injections; polysorbate 20; monobasic sodium phosphate; sodium chloride; acetic acid; leucine; phenylalanine; methionine; lysine hydrochloride; isoleucine; valine; histidine; threonine; tryptophan; alanine; arginine; proline; tyrosine; serine; sodium acetate; dibasic potassium phosphate; magnesium chloride hexahydrate; glycine - twinrix (720/20) is indicated for active immunisation against hepatitis a and hepatitis b virus infection in adults and children from 1 year of age. twinrix junior (360/10) is indicated for use in children aged 1 to 15 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis a virus antigen, quantity: 720 elisa unit/ml; hepatitis b surface antigen recombinant, quantity: 20 microgram/ml - injection, suspension - excipient ingredients: trometamol; aluminium hydroxide hydrate; water for injections; polysorbate 20; dibasic sodium phosphate heptahydrate; neomycin sulfate; monobasic sodium phosphate; formaldehyde solution; aluminium phosphate; sodium chloride; acetic acid; leucine; phenylalanine; methionine; lysine hydrochloride; isoleucine; valine; histidine; threonine; tryptophan; alanine; arginine; proline; tyrosine; serine; sodium acetate; dibasic potassium phosphate; magnesium chloride hexahydrate; glycine - twinrix (720/20) is indicated for active immunisation against hepatitis a and hepatitis b virus infection in adults and children from 1 year of age. twinrix junior (360/10) is indicated for use in children aged 1 to 15 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose monohydrate, quantity: 42.5 g/l; calcium chloride dihydrate, quantity: 0.184 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; sodium chloride, quantity: 5.38 g/l; sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l - solution, irrigation - excipient ingredients: water for injections - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose monohydrate, quantity: 25 g/l; calcium chloride dihydrate, quantity: 0.184 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; sodium chloride, quantity: 5.38 g/l; sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l - solution, irrigation - excipient ingredients: water for injections - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.